Next generation cancer diagnostics - Global Market Outlook (2015-2022)
According to Stratistics MRC, the Global Next Generation Cancer Diagnostics market is estimated at $2.95 billion in 2015 and is expected to grow at a CAGR of 32.6% to reach $20.93 billion by 2022. Growing incidence of oncology diseases is expected to boost the demand for next generation cancer diagnostic tests market. However, lack of sufficient reimbursement policies for novel technologies and stringent regulatory procedures are the major factors that can hamper the global next generation cancer diagnostics market growth over the forecast period.
The largest segment of the global market for next generation cancer diagnostics is Blood-born cancers. Asia Pacific is likely to be one of the fastest growing regions of this sector and is anticipated to grow at a lucrative rate. A largely untouched market base which has exhibited technological advancements in healthcare research during the past decade is responsible for rapid growth in this region.
Some of the key players in the global Next Generation Cancer Diagnostics market are Thermo Fisher Scientific, Inc., Roche, Philips Electronics NV, Perkin Elmer Inc., Novartis AG, Lab-on-a-chip, Illumina, Inc., Agilent Technologies Inc, Siemens Healthcare, Johnson & Johnson, Hologic Inc., GE Healthcare, C.R. Bard, Inc and Abbot.
Cancer Type Covered:
The largest segment of the global market for next generation cancer diagnostics is Blood-born cancers. Asia Pacific is likely to be one of the fastest growing regions of this sector and is anticipated to grow at a lucrative rate. A largely untouched market base which has exhibited technological advancements in healthcare research during the past decade is responsible for rapid growth in this region.
Some of the key players in the global Next Generation Cancer Diagnostics market are Thermo Fisher Scientific, Inc., Roche, Philips Electronics NV, Perkin Elmer Inc., Novartis AG, Lab-on-a-chip, Illumina, Inc., Agilent Technologies Inc, Siemens Healthcare, Johnson & Johnson, Hologic Inc., GE Healthcare, C.R. Bard, Inc and Abbot.
Cancer Type Covered:
- Lung Cancer
- Colorectal Cancer
- Cervical Cancer
- Breast Cancer
- Other Cancer Types
- Therapeutic Monitoring
- Risk analysis
- Prognostics diagnosis
- Companion Diagnostics
- Cancer Screening
- Platform-Based Diagnostics
- Polymerase Chain Reaction (PCR)
- Next-Generation Sequencing (NGS)
- Microarrays
- In Situ Hybridization (ISH)
- Immunohistochemistry (IHC)
- Flow Cytometry
- Other Technologies
- Instrument-Based
- Diagnostic Imaging
- Ultrasound
- Mammography
- Biopsies
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- Italy
- UK
- Spain
- Rest of Europe
- Asia Pacific
- Japan
- China
- India
- Australia
- New Zealand
- Rest of Asia Pacific
- Rest of the World
- Middle East
- Brazil
- Argentina
- South Africa
- Egypt
- Market share assessments for the regional and country level segments
- Market share analysis of the top industry players
- Strategic recommendations for the new entrants
- Market forecasts for a minimum of 7 years of all the mentioned segments, sub segments and the regional markets
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements
1 EXECUTIVE SUMMARY
2 PREFACE
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions
3 MARKET TREND ANALYSIS
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Application Analysis
3.7 Technology Analysis
3.8 Emerging markets
4 PORTERS FIVE FORCE ANALYSIS
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 GLOBAL NEXT GENERATION CANCER DIAGNOSTICS MARKET, BY APPLICATION
5.1 Introduction
5.2 Proteomic Analysis
5.3 Epigenetic Analysis
5.4 Genetic Analysis
5.5 Biomarker Development
5.6 CTC Analysis
6 GLOBAL NEXT GENERATION CANCER DIAGNOSTICS MARKET, BY TECHNOLOGY
6.1 Introduction
6.2 Lab-on-a-chip
6.3 DNA Microarrays
6.4 Multiplexed assays
6.5 RT-PCR & Multiplexing
6.6 Protein Microarrays
6.7 Cellular capture and identification
6.8 Next Generation Sequencing
6.9 Benchtop Sequencers
6.10 Other Technologies
7 GLOBAL NEXT GENERATION CANCER DIAGNOSTICS MARKET, BY FUNCTION
7.1 Introduction
7.2 Prognosis Diagnostics
7.3 Companion Diagnostics
7.4 Cancer Screening
7.5 Risk Analysis
7.6 Therapeutic Monitoring
8 GLOBAL NEXT GENERATION CANCER DIAGNOSTICS MARKET, BY CANCER TYPE
8.1 Introduction
8.2 Sex-related tumors
8.2.1 Cervical Cancer
8.2.2 Breast Cancer
8.2.3 Ovarian Cancer
8.2.4 Prostate Cancer
8.3 Blood-born cancers
8.3.1 Myeloma
8.3.2 Leukemia
8.3.3 Lymphoma
8.4 Lung Cancer
8.5 Solid tumors
8.6 Colorectal Cancer
8.7 Other Cancers
9 GLOBAL NEXT GENERATION CANCER DIAGNOSTICS MARKET, BY GEOGRAPHY
9.1 North America
9.1.1 US
9.1.2 Canada
9.1.3 Mexico
9.2 Europe
9.2.1 Germany
9.2.2 France
9.2.3 Italy
9.2.4 UK
9.2.5 Spain
9.2.6 Rest of Europe
9.3 Asia Pacific
9.3.1 Japan
9.3.2 China
9.3.3 India
9.3.4 Australia
9.3.5 New Zealand
9.3.6 Rest of Asia Pacific
9.4 Rest of the World
9.4.1 Middle East
9.4.2 Brazil
9.4.3 Argentina
9.4.4 South Africa
9.4.5 Egypt
10 KEY DEVELOPMENTS
10.1 Agreements, Partnerships, Collaborations and Joint Ventures
10.2 Acquisitions & Mergers
10.3 New Product Launch
10.4 Expansions
10.5 Other Key Strategies
11 COMPANY PROFILING
11.1 Abbott Laboratories
11.2 Agilent Technologies Inc
11.3 GE Healthcare
11.4 Genomic Health Inc.
11.5 Hologic Inc.
11.6 Illumina Inc.
11.7 Johnson & Johnson
11.8 Myriad Genetics Inc.
11.9 Novartis AG
11.10 Opko Health Inc.
11.11 Perkin Elmer Inc.
11.12 Philips Electronics NV
11.13 Qiagen
11.14 Roche Holding AG
11.15 Thermo Fisher Scientific Inc.
2 PREFACE
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions
3 MARKET TREND ANALYSIS
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Application Analysis
3.7 Technology Analysis
3.8 Emerging markets
4 PORTERS FIVE FORCE ANALYSIS
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 GLOBAL NEXT GENERATION CANCER DIAGNOSTICS MARKET, BY APPLICATION
5.1 Introduction
5.2 Proteomic Analysis
5.3 Epigenetic Analysis
5.4 Genetic Analysis
5.5 Biomarker Development
5.6 CTC Analysis
6 GLOBAL NEXT GENERATION CANCER DIAGNOSTICS MARKET, BY TECHNOLOGY
6.1 Introduction
6.2 Lab-on-a-chip
6.3 DNA Microarrays
6.4 Multiplexed assays
6.5 RT-PCR & Multiplexing
6.6 Protein Microarrays
6.7 Cellular capture and identification
6.8 Next Generation Sequencing
6.9 Benchtop Sequencers
6.10 Other Technologies
7 GLOBAL NEXT GENERATION CANCER DIAGNOSTICS MARKET, BY FUNCTION
7.1 Introduction
7.2 Prognosis Diagnostics
7.3 Companion Diagnostics
7.4 Cancer Screening
7.5 Risk Analysis
7.6 Therapeutic Monitoring
8 GLOBAL NEXT GENERATION CANCER DIAGNOSTICS MARKET, BY CANCER TYPE
8.1 Introduction
8.2 Sex-related tumors
8.2.1 Cervical Cancer
8.2.2 Breast Cancer
8.2.3 Ovarian Cancer
8.2.4 Prostate Cancer
8.3 Blood-born cancers
8.3.1 Myeloma
8.3.2 Leukemia
8.3.3 Lymphoma
8.4 Lung Cancer
8.5 Solid tumors
8.6 Colorectal Cancer
8.7 Other Cancers
9 GLOBAL NEXT GENERATION CANCER DIAGNOSTICS MARKET, BY GEOGRAPHY
9.1 North America
9.1.1 US
9.1.2 Canada
9.1.3 Mexico
9.2 Europe
9.2.1 Germany
9.2.2 France
9.2.3 Italy
9.2.4 UK
9.2.5 Spain
9.2.6 Rest of Europe
9.3 Asia Pacific
9.3.1 Japan
9.3.2 China
9.3.3 India
9.3.4 Australia
9.3.5 New Zealand
9.3.6 Rest of Asia Pacific
9.4 Rest of the World
9.4.1 Middle East
9.4.2 Brazil
9.4.3 Argentina
9.4.4 South Africa
9.4.5 Egypt
10 KEY DEVELOPMENTS
10.1 Agreements, Partnerships, Collaborations and Joint Ventures
10.2 Acquisitions & Mergers
10.3 New Product Launch
10.4 Expansions
10.5 Other Key Strategies
11 COMPANY PROFILING
11.1 Abbott Laboratories
11.2 Agilent Technologies Inc
11.3 GE Healthcare
11.4 Genomic Health Inc.
11.5 Hologic Inc.
11.6 Illumina Inc.
11.7 Johnson & Johnson
11.8 Myriad Genetics Inc.
11.9 Novartis AG
11.10 Opko Health Inc.
11.11 Perkin Elmer Inc.
11.12 Philips Electronics NV
11.13 Qiagen
11.14 Roche Holding AG
11.15 Thermo Fisher Scientific Inc.
LIST OF TABLES
Global Next Generation Cancer Diagnostics Market Outlook, By Region (2013-2022) ($MN)
Global Next Generation Cancer Diagnostics Market Outlook, By Application (2013-2022) ($MN)
Global Next Generation Cancer Diagnostics Market Outlook, By Proteomic Analysis (2013-2022) ($MN)
Global Next Generation Cancer Diagnostics Market Outlook, By Epigenetic Analysis (2013-2022) ($MN)
Global Next Generation Cancer Diagnostics Market Outlook, By Genetic Analysis (2013-2022) ($MN)
Global Next Generation Cancer Diagnostics Market Outlook, By Biomarker Development (2013-2022) ($MN)
Global Next Generation Cancer Diagnostics Market Outlook, By CTC Analysis (2013-2022) ($MN)
Global Next Generation Cancer Diagnostics Market Outlook, By Technology (2013-2022) ($MN)
Global Next Generation Cancer Diagnostics Market Outlook, By Lab-on-a-chip (2013-2022) ($MN)
Global Next Generation Cancer Diagnostics Market Outlook, By DNA Microarrays (2013-2022) ($MN)
Global Next Generation Cancer Diagnostics Market Outlook, By Multiplexed assays (2013-2022) ($MN)
Global Next Generation Cancer Diagnostics Market Outlook, By RT-PCR & Multiplexing (2013-2022) ($MN)
Global Next Generation Cancer Diagnostics Market Outlook, By Protein Microarrays (2013-2022) ($MN)
Global Next Generation Cancer Diagnostics Market Outlook, By Cellular capture and identification (2013-2022) ($MN)
Global Next Generation Cancer Diagnostics Market Outlook, By Next Generation Sequencing (2013-2022) ($MN)
Global Next Generation Cancer Diagnostics Market Outlook, By Benchtop Sequencers (2013-2022) ($MN)
Global Next Generation Cancer Diagnostics Market Outlook, By Other Technologies (2013-2022) ($MN)
Global Next Generation Cancer Diagnostics Market Outlook, By Function (2013-2022) ($MN)
Global Next Generation Cancer Diagnostics Market Outlook, By Prognosis Diagnostics (2013-2022) ($MN)
Global Next Generation Cancer Diagnostics Market Outlook, By Companion Diagnostics (2013-2022) ($MN)
Global Next Generation Cancer Diagnostics Market Outlook, By Cancer Screening (2013-2022) ($MN)
Global Next Generation Cancer Diagnostics Market Outlook, By Risk Analysis (2013-2022) ($MN)
Global Next Generation Cancer Diagnostics Market Outlook, By Therapeutic Monitoring (2013-2022) ($MN)
Global Next Generation Cancer Diagnostics Market Outlook, By Cancer Type (2013-2022) ($MN)
Global Next Generation Cancer Diagnostics Market Outlook, By Sex-related tumors (2013-2022) ($MN)
Global Next Generation Cancer Diagnostics Market Outlook, By Cervical Cancer (2013-2022) ($MN)
Global Next Generation Cancer Diagnostics Market Outlook, By Breast Cancer (2013-2022) ($MN)
Global Next Generation Cancer Diagnostics Market Outlook, By Ovarian Cancer (2013-2022) ($MN)
Global Next Generation Cancer Diagnostics Market Outlook, By Prostate Cancer (2013-2022) ($MN)
Global Next Generation Cancer Diagnostics Market Outlook, By Blood-born cancers (2013-2022) ($MN)
Global Next Generation Cancer Diagnostics Market Outlook, By Myeloma (2013-2022) ($MN)
Global Next Generation Cancer Diagnostics Market Outlook, By Leukemia (2013-2022) ($MN)
Global Next Generation Cancer Diagnostics Market Outlook, By Lymphoma (2013-2022) ($MN)
Global Next Generation Cancer Diagnostics Market Outlook, By Lung Cancer (2013-2022) ($MN)
Global Next Generation Cancer Diagnostics Market Outlook, By Solid tumors (2013-2022) ($MN)
Global Next Generation Cancer Diagnostics Market Outlook, By Colorectal Cancer (2013-2022) ($MN)
Global Next Generation Cancer Diagnostics Market Outlook, By Other Cancers (2013-2022) ($MN)
North America Next Generation Cancer Diagnostics Market Outlook, By Application (2013-2022) ($MN)
North America Next Generation Cancer Diagnostics Market Outlook, By Proteomic Analysis (2013-2022) ($MN)
North America Next Generation Cancer Diagnostics Market Outlook, By Epigenetic Analysis (2013-2022) ($MN)
North America Next Generation Cancer Diagnostics Market Outlook, By Genetic Analysis (2013-2022) ($MN)
North America Next Generation Cancer Diagnostics Market Outlook, By Biomarker Development (2013-2022) ($MN)
North America Next Generation Cancer Diagnostics Market Outlook, By CTC Analysis (2013-2022) ($MN)
North America Next Generation Cancer Diagnostics Market Outlook, By Technology (2013-2022) ($MN)
North America Next Generation Cancer Diagnostics Market Outlook, By Lab-on-a-chip (2013-2022) ($MN)
North America Next Generation Cancer Diagnostics Market Outlook, By DNA Microarrays (2013-2022) ($MN)
North America Next Generation Cancer Diagnostics Market Outlook, By Multiplexed assays (2013-2022) ($MN)
North America Next Generation Cancer Diagnostics Market Outlook, By RT-PCR & Multiplexing (2013-2022) ($MN)
North America Next Generation Cancer Diagnostics Market Outlook, By Protein Microarrays (2013-2022) ($MN)
North America Next Generation Cancer Diagnostics Market Outlook, By Cellular capture and identification (2013-2022) ($MN)
North America Next Generation Cancer Diagnostics Market Outlook, By Next Generation Sequencing (2013-2022) ($MN)
North America Next Generation Cancer Diagnostics Market Outlook, By Benchtop Sequencers (2013-2022) ($MN)
North America Next Generation Cancer Diagnostics Market Outlook, By Other Technologies (2013-2022) ($MN)
North America Next Generation Cancer Diagnostics Market Outlook, By Function (2013-2022) ($MN)
North America Next Generation Cancer Diagnostics Market Outlook, By Prognosis Diagnostics (2013-2022) ($MN)
North America Next Generation Cancer Diagnostics Market Outlook, By Companion Diagnostics (2013-2022) ($MN)
North America Next Generation Cancer Diagnostics Market Outlook, By Cancer Screening (2013-2022) ($MN)
North America Next Generation Cancer Diagnostics Market Outlook, By Risk Analysis (2013-2022) ($MN)
North America Next Generation Cancer Diagnostics Market Outlook, By Therapeutic Monitoring (2013-2022) ($MN)
North America Next Generation Cancer Diagnostics Market Outlook, By Cancer Type (2013-2022) ($MN)
North America Next Generation Cancer Diagnostics Market Outlook, By Sex-related tumors (2013-2022) ($MN)
North America Next Generation Cancer Diagnostics Market Outlook, By Cervical Cancer (2013-2022) ($MN)
North America Next Generation Cancer Diagnostics Market Outlook, By Breast Cancer (2013-2022) ($MN)
North America Next Generation Cancer Diagnostics Market Outlook, By Ovarian Cancer (2013-2022) ($MN)
North America Next Generation Cancer Diagnostics Market Outlook, By Prostate Cancer (2013-2022) ($MN)
North America Next Generation Cancer Diagnostics Market Outlook, By Blood-born cancers (2013-2022) ($MN)
North America Next Generation Cancer Diagnostics Market Outlook, By Myeloma (2013-2022) ($MN)
North America Next Generation Cancer Diagnostics Market Outlook, By Leukemia (2013-2022) ($MN)
North America Next Generation Cancer Diagnostics Market Outlook, By Lymphoma (2013-2022) ($MN)
North America Next Generation Cancer Diagnostics Market Outlook, By Lung Cancer (2013-2022) ($MN)
North America Next Generation Cancer Diagnostics Market Outlook, By Solid tumors (2013-2022) ($MN)
North America Next Generation Cancer Diagnostics Market Outlook, By Colorectal Cancer (2013-2022) ($MN)
North America Next Generation Cancer Diagnostics Market Outlook, By Other Cancers (2013-2022) ($MN)
Europe Next Generation Cancer Diagnostics Market Outlook, By Application (2013-2022) ($MN)
Europe Next Generation Cancer Diagnostics Market Outlook, By Proteomic Analysis (2013-2022) ($MN)
Europe Next Generation Cancer Diagnostics Market Outlook, By Epigenetic Analysis (2013-2022) ($MN)
Europe Next Generation Cancer Diagnostics Market Outlook, By Genetic Analysis (2013-2022) ($MN)
Europe Next Generation Cancer Diagnostics Market Outlook, By Biomarker Development (2013-2022) ($MN)
Europe Next Generation Cancer Diagnostics Market Outlook, By CTC Analysis (2013-2022) ($MN)
Europe Next Generation Cancer Diagnostics Market Outlook, By Technology (2013-2022) ($MN)
Europe Next Generation Cancer Diagnostics Market Outlook, By Lab-on-a-chip (2013-2022) ($MN)
Europe Next Generation Cancer Diagnostics Market Outlook, By DNA Microarrays (2013-2022) ($MN)
Europe Next Generation Cancer Diagnostics Market Outlook, By Multiplexed assays (2013-2022) ($MN)
Europe Next Generation Cancer Diagnostics Market Outlook, By RT-PCR & Multiplexing (2013-2022) ($MN)
Europe Next Generation Cancer Diagnostics Market Outlook, By Protein Microarrays (2013-2022) ($MN)
Europe Next Generation Cancer Diagnostics Market Outlook, By Cellular capture and identification (2013-2022) ($MN)
Europe Next Generation Cancer Diagnostics Market Outlook, By Next Generation Sequencing (2013-2022) ($MN)
Europe Next Generation Cancer Diagnostics Market Outlook, By Benchtop Sequencers (2013-2022) ($MN)
Europe Next Generation Cancer Diagnostics Market Outlook, By Other Technologies (2013-2022) ($MN)
Europe Next Generation Cancer Diagnostics Market Outlook, By Function (2013-2022) ($MN)
Europe Next Generation Cancer Diagnostics Market Outlook, By Prognosis Diagnostics (2013-2022) ($MN)
Europe Next Generation Cancer Diagnostics Market Outlook, By Companion Diagnostics (2013-2022) ($MN)
Europe Next Generation Cancer Diagnostics Market Outlook, By Cancer Screening (2013-2022) ($MN)
Europe Next Generation Cancer Diagnostics Market Outlook, By Risk Analysis (2013-2022) ($MN)
Europe Next Generation Cancer Diagnostics Market Outlook, By Therapeutic Monitoring (2013-2022) ($MN)
Europe Next Generation Cancer Diagnostics Market Outlook, By Cancer Type (2013-2022) ($MN)
Europe Next Generation Cancer Diagnostics Market Outlook, By Sex-related tumors (2013-2022) ($MN)
Europe Next Generation Cancer Diagnostics Market Outlook, By Cervical Cancer (2013-2022) ($MN)
Europe Next Generation Cancer Diagnostics Market Outlook, By Breast Cancer (2013-2022) ($MN)
Europe Next Generation Cancer Diagnostics Market Outlook, By Ovarian Cancer (2013-2022) ($MN)
Europe Next Generation Cancer Diagnostics Market Outlook, By Prostate Cancer (2013-2022) ($MN)
Europe Next Generation Cancer Diagnostics Market Outlook, By Blood-born cancers (2013-2022) ($MN)
Europe Next Generation Cancer Diagnostics Market Outlook, By Myeloma (2013-2022) ($MN)
Europe Next Generation Cancer Diagnostics Market Outlook, By Leukemia (2013-2022) ($MN)
Europe Next Generation Cancer Diagnostics Market Outlook, By Lymphoma (2013-2022) ($MN)
Europe Next Generation Cancer Diagnostics Market Outlook, By Lung Cancer (2013-2022) ($MN)
Europe Next Generation Cancer Diagnostics Market Outlook, By Solid tumors (2013-2022) ($MN)
Europe Next Generation Cancer Diagnostics Market Outlook, By Colorectal Cancer (2013-2022) ($MN)
Europe Next Generation Cancer Diagnostics Market Outlook, By Other Cancers (2013-2022) ($MN)
Asia Pacific Next Generation Cancer Diagnostics Market Outlook, By Application (2013-2022) ($MN)
Asia Pacific Next Generation Cancer Diagnostics Market Outlook, By Proteomic Analysis (2013-2022) ($MN)
Asia Pacific Next Generation Cancer Diagnostics Market Outlook, By Epigenetic Analysis (2013-2022) ($MN)
Asia Pacific Next Generation Cancer Diagnostics Market Outlook, By Genetic Analysis (2013-2022) ($MN)
Asia Pacific Next Generation Cancer Diagnostics Market Outlook, By Biomarker Development (2013-2022) ($MN)
Asia Pacific Next Generation Cancer Diagnostics Market Outlook, By CTC Analysis (2013-2022) ($MN)
Asia Pacific Next Generation Cancer Diagnostics Market Outlook, By Technology (2013-2022) ($MN)
Asia Pacific Next Generation Cancer Diagnostics Market Outlook, By Lab-on-a-chip (2013-2022) ($MN)
Asia Pacific Next Generation Cancer Diagnostics Market Outlook, By DNA Microarrays (2013-2022) ($MN)
Asia Pacific Next Generation Cancer Diagnostics Market Outlook, By Multiplexed assays (2013-2022) ($MN)
Asia Pacific Next Generation Cancer Diagnostics Market Outlook, By RT-PCR & Multiplexing (2013-2022) ($MN)
Asia Pacific Next Generation Cancer Diagnostics Market Outlook, By Protein Microarrays (2013-2022) ($MN)
Asia Pacific Next Generation Cancer Diagnostics Market Outlook, By Cellular capture and identification (2013-2022) ($MN)
Asia Pacific Next Generation Cancer Diagnostics Market Outlook, By Next Generation Sequencing (2013-2022) ($MN)
Asia Pacific Next Generation Cancer Diagnostics Market Outlook, By Benchtop Sequencers (2013-2022) ($MN)
Asia Pacific Next Generation Cancer Diagnostics Market Outlook, By Other Technologies (2013-2022) ($MN)
Asia Pacific Next Generation Cancer Diagnostics Market Outlook, By Function (2013-2022) ($MN)
Asia Pacific Next Generation Cancer Diagnostics Market Outlook, By Prognosis Diagnostics (2013-2022) ($MN)
Asia Pacific Next Generation Cancer Diagnostics Market Outlook, By Companion Diagnostics (2013-2022) ($MN)
Asia Pacific Next Generation Cancer Diagnostics Market Outlook, By Cancer Screening (2013-2022) ($MN)
Asia Pacific Next Generation Cancer Diagnostics Market Outlook, By Risk Analysis (2013-2022) ($MN)
Asia Pacific Next Generation Cancer Diagnostics Market Outlook, By Therapeutic Monitoring (2013-2022) ($MN)
Asia Pacific Next Generation Cancer Diagnostics Market Outlook, By Cancer Type (2013-2022) ($MN)
Asia Pacific Next Generation Cancer Diagnostics Market Outlook, By Sex-related tumors (2013-2022) ($MN)
Asia Pacific Next Generation Cancer Diagnostics Market Outlook, By Cervical Cancer (2013-2022) ($MN)
Asia Pacific Next Generation Cancer Diagnostics Market Outlook, By Breast Cancer (2013-2022) ($MN)
Asia Pacific Next Generation Cancer Diagnostics Market Outlook, By Ovarian Cancer (2013-2022) ($MN)
Asia Pacific Next Generation Cancer Diagnostics Market Outlook, By Prostate Cancer (2013-2022) ($MN)
Asia Pacific Next Generation Cancer Diagnostics Market Outlook, By Blood-born cancers (2013-2022) ($MN)
Asia Pacific Next Generation Cancer Diagnostics Market Outlook, By Myeloma (2013-2022) ($MN)
Asia Pacific Next Generation Cancer Diagnostics Market Outlook, By Leukemia (2013-2022) ($MN)
Asia Pacific Next Generation Cancer Diagnostics Market Outlook, By Lymphoma (2013-2022) ($MN)
Asia Pacific Next Generation Cancer Diagnostics Market Outlook, By Lung Cancer (2013-2022) ($MN)
Asia Pacific Next Generation Cancer Diagnostics Market Outlook, By Solid tumors (2013-2022) ($MN)
Asia Pacific Next Generation Cancer Diagnostics Market Outlook, By Colorectal Cancer (2013-2022) ($MN)
Asia Pacific Next Generation Cancer Diagnostics Market Outlook, By Other Cancers (2013-2022) ($MN)
Rest of the World Next Generation Cancer Diagnostics Market Outlook, By Application (2013-2022) ($MN)
Rest of the World Next Generation Cancer Diagnostics Market Outlook, By Proteomic Analysis (2013-2022) ($MN)
Rest of the World Next Generation Cancer Diagnostics Market Outlook, By Epigenetic Analysis (2013-2022) ($MN)
Rest of the World Next Generation Cancer Diagnostics Market Outlook, By Genetic Analysis (2013-2022) ($MN)
Rest of the World Next Generation Cancer Diagnostics Market Outlook, By Biomarker Development (2013-2022) ($MN)
Rest of the World Next Generation Cancer Diagnostics Market Outlook, By CTC Analysis (2013-2022) ($MN)
Rest of the World Next Generation Cancer Diagnostics Market Outlook, By Technology (2013-2022) ($MN)
Rest of the World Next Generation Cancer Diagnostics Market Outlook, By Lab-on-a-chip (2013-2022) ($MN)
Rest of the World Next Generation Cancer Diagnostics Market Outlook, By DNA Microarrays (2013-2022) ($MN)
Rest of the World Next Generation Cancer Diagnostics Market Outlook, By Multiplexed assays (2013-2022) ($MN)
Rest of the World Next Generation Cancer Diagnostics Market Outlook, By RT-PCR & Multiplexing (2013-2022) ($MN)
Rest of the World Next Generation Cancer Diagnostics Market Outlook, By Protein Microarrays (2013-2022) ($MN)
Rest of the World Next Generation Cancer Diagnostics Market Outlook, By Cellular capture and identification (2013-2022) ($MN)
Rest of the World Next Generation Cancer Diagnostics Market Outlook, By Next Generation Sequencing (2013-2022) ($MN)
Rest of the World Next Generation Cancer Diagnostics Market Outlook, By Benchtop Sequencers (2013-2022) ($MN)
Rest of the World Next Generation Cancer Diagnostics Market Outlook, By Other Technologies (2013-2022) ($MN)
Rest of the World Next Generation Cancer Diagnostics Market Outlook, By Function (2013-2022) ($MN)
Rest of the World Next Generation Cancer Diagnostics Market Outlook, By Prognosis Diagnostics (2013-2022) ($MN)
Rest of the World Next Generation Cancer Diagnostics Market Outlook, By Companion Diagnostics (2013-2022) ($MN)
Rest of the World Next Generation Cancer Diagnostics Market Outlook, By Cancer Screening (2013-2022) ($MN)
Rest of the World Next Generation Cancer Diagnostics Market Outlook, By Risk Analysis (2013-2022) ($MN)
Rest of the World Next Generation Cancer Diagnostics Market Outlook, By Therapeutic Monitoring (2013-2022) ($MN)
Rest of the World Next Generation Cancer Diagnostics Market Outlook, By Cancer Type (2013-2022) ($MN)
Rest of the World Next Generation Cancer Diagnostics Market Outlook, By Sex-related tumors (2013-2022) ($MN)
Rest of the World Next Generation Cancer Diagnostics Market Outlook, By Cervical Cancer (2013-2022) ($MN)
Rest of the World Next Generation Cancer Diagnostics Market Outlook, By Breast Cancer (2013-2022) ($MN)
Rest of the World Next Generation Cancer Diagnostics Market Outlook, By Ovarian Cancer (2013-2022) ($MN)
Rest of the World Next Generation Cancer Diagnostics Market Outlook, By Prostate Cancer (2013-2022) ($MN)
Rest of the World Next Generation Cancer Diagnostics Market Outlook, By Blood-born cancers (2013-2022) ($MN)
Rest of the World Next Generation Cancer Diagnostics Market Outlook, By Myeloma (2013-2022) ($MN)
Rest of the World Next Generation Cancer Diagnostics Market Outlook, By Leukemia (2013-2022) ($MN)
Rest of the World Next Generation Cancer Diagnostics Market Outlook, By Lymphoma (2013-2022) ($MN)
Rest of the World Next Generation Cancer Diagnostics Market Outlook, By Lung Cancer (2013-2022) ($MN)
Rest of the World Next Generation Cancer Diagnostics Market Outlook, By Solid tumors (2013-2022) ($MN)
Rest of the World Next Generation Cancer Diagnostics Market Outlook, By Colorectal Cancer (2013-2022) ($MN)
Rest of the World Next Generation Cancer Diagnostics Market Outlook, By Other Cancers (2013-2022) ($MN)
Global Next Generation Cancer Diagnostics Market Outlook, By Region (2013-2022) ($MN)
Global Next Generation Cancer Diagnostics Market Outlook, By Application (2013-2022) ($MN)
Global Next Generation Cancer Diagnostics Market Outlook, By Proteomic Analysis (2013-2022) ($MN)
Global Next Generation Cancer Diagnostics Market Outlook, By Epigenetic Analysis (2013-2022) ($MN)
Global Next Generation Cancer Diagnostics Market Outlook, By Genetic Analysis (2013-2022) ($MN)
Global Next Generation Cancer Diagnostics Market Outlook, By Biomarker Development (2013-2022) ($MN)
Global Next Generation Cancer Diagnostics Market Outlook, By CTC Analysis (2013-2022) ($MN)
Global Next Generation Cancer Diagnostics Market Outlook, By Technology (2013-2022) ($MN)
Global Next Generation Cancer Diagnostics Market Outlook, By Lab-on-a-chip (2013-2022) ($MN)
Global Next Generation Cancer Diagnostics Market Outlook, By DNA Microarrays (2013-2022) ($MN)
Global Next Generation Cancer Diagnostics Market Outlook, By Multiplexed assays (2013-2022) ($MN)
Global Next Generation Cancer Diagnostics Market Outlook, By RT-PCR & Multiplexing (2013-2022) ($MN)
Global Next Generation Cancer Diagnostics Market Outlook, By Protein Microarrays (2013-2022) ($MN)
Global Next Generation Cancer Diagnostics Market Outlook, By Cellular capture and identification (2013-2022) ($MN)
Global Next Generation Cancer Diagnostics Market Outlook, By Next Generation Sequencing (2013-2022) ($MN)
Global Next Generation Cancer Diagnostics Market Outlook, By Benchtop Sequencers (2013-2022) ($MN)
Global Next Generation Cancer Diagnostics Market Outlook, By Other Technologies (2013-2022) ($MN)
Global Next Generation Cancer Diagnostics Market Outlook, By Function (2013-2022) ($MN)
Global Next Generation Cancer Diagnostics Market Outlook, By Prognosis Diagnostics (2013-2022) ($MN)
Global Next Generation Cancer Diagnostics Market Outlook, By Companion Diagnostics (2013-2022) ($MN)
Global Next Generation Cancer Diagnostics Market Outlook, By Cancer Screening (2013-2022) ($MN)
Global Next Generation Cancer Diagnostics Market Outlook, By Risk Analysis (2013-2022) ($MN)
Global Next Generation Cancer Diagnostics Market Outlook, By Therapeutic Monitoring (2013-2022) ($MN)
Global Next Generation Cancer Diagnostics Market Outlook, By Cancer Type (2013-2022) ($MN)
Global Next Generation Cancer Diagnostics Market Outlook, By Sex-related tumors (2013-2022) ($MN)
Global Next Generation Cancer Diagnostics Market Outlook, By Cervical Cancer (2013-2022) ($MN)
Global Next Generation Cancer Diagnostics Market Outlook, By Breast Cancer (2013-2022) ($MN)
Global Next Generation Cancer Diagnostics Market Outlook, By Ovarian Cancer (2013-2022) ($MN)
Global Next Generation Cancer Diagnostics Market Outlook, By Prostate Cancer (2013-2022) ($MN)
Global Next Generation Cancer Diagnostics Market Outlook, By Blood-born cancers (2013-2022) ($MN)
Global Next Generation Cancer Diagnostics Market Outlook, By Myeloma (2013-2022) ($MN)
Global Next Generation Cancer Diagnostics Market Outlook, By Leukemia (2013-2022) ($MN)
Global Next Generation Cancer Diagnostics Market Outlook, By Lymphoma (2013-2022) ($MN)
Global Next Generation Cancer Diagnostics Market Outlook, By Lung Cancer (2013-2022) ($MN)
Global Next Generation Cancer Diagnostics Market Outlook, By Solid tumors (2013-2022) ($MN)
Global Next Generation Cancer Diagnostics Market Outlook, By Colorectal Cancer (2013-2022) ($MN)
Global Next Generation Cancer Diagnostics Market Outlook, By Other Cancers (2013-2022) ($MN)
North America Next Generation Cancer Diagnostics Market Outlook, By Application (2013-2022) ($MN)
North America Next Generation Cancer Diagnostics Market Outlook, By Proteomic Analysis (2013-2022) ($MN)
North America Next Generation Cancer Diagnostics Market Outlook, By Epigenetic Analysis (2013-2022) ($MN)
North America Next Generation Cancer Diagnostics Market Outlook, By Genetic Analysis (2013-2022) ($MN)
North America Next Generation Cancer Diagnostics Market Outlook, By Biomarker Development (2013-2022) ($MN)
North America Next Generation Cancer Diagnostics Market Outlook, By CTC Analysis (2013-2022) ($MN)
North America Next Generation Cancer Diagnostics Market Outlook, By Technology (2013-2022) ($MN)
North America Next Generation Cancer Diagnostics Market Outlook, By Lab-on-a-chip (2013-2022) ($MN)
North America Next Generation Cancer Diagnostics Market Outlook, By DNA Microarrays (2013-2022) ($MN)
North America Next Generation Cancer Diagnostics Market Outlook, By Multiplexed assays (2013-2022) ($MN)
North America Next Generation Cancer Diagnostics Market Outlook, By RT-PCR & Multiplexing (2013-2022) ($MN)
North America Next Generation Cancer Diagnostics Market Outlook, By Protein Microarrays (2013-2022) ($MN)
North America Next Generation Cancer Diagnostics Market Outlook, By Cellular capture and identification (2013-2022) ($MN)
North America Next Generation Cancer Diagnostics Market Outlook, By Next Generation Sequencing (2013-2022) ($MN)
North America Next Generation Cancer Diagnostics Market Outlook, By Benchtop Sequencers (2013-2022) ($MN)
North America Next Generation Cancer Diagnostics Market Outlook, By Other Technologies (2013-2022) ($MN)
North America Next Generation Cancer Diagnostics Market Outlook, By Function (2013-2022) ($MN)
North America Next Generation Cancer Diagnostics Market Outlook, By Prognosis Diagnostics (2013-2022) ($MN)
North America Next Generation Cancer Diagnostics Market Outlook, By Companion Diagnostics (2013-2022) ($MN)
North America Next Generation Cancer Diagnostics Market Outlook, By Cancer Screening (2013-2022) ($MN)
North America Next Generation Cancer Diagnostics Market Outlook, By Risk Analysis (2013-2022) ($MN)
North America Next Generation Cancer Diagnostics Market Outlook, By Therapeutic Monitoring (2013-2022) ($MN)
North America Next Generation Cancer Diagnostics Market Outlook, By Cancer Type (2013-2022) ($MN)
North America Next Generation Cancer Diagnostics Market Outlook, By Sex-related tumors (2013-2022) ($MN)
North America Next Generation Cancer Diagnostics Market Outlook, By Cervical Cancer (2013-2022) ($MN)
North America Next Generation Cancer Diagnostics Market Outlook, By Breast Cancer (2013-2022) ($MN)
North America Next Generation Cancer Diagnostics Market Outlook, By Ovarian Cancer (2013-2022) ($MN)
North America Next Generation Cancer Diagnostics Market Outlook, By Prostate Cancer (2013-2022) ($MN)
North America Next Generation Cancer Diagnostics Market Outlook, By Blood-born cancers (2013-2022) ($MN)
North America Next Generation Cancer Diagnostics Market Outlook, By Myeloma (2013-2022) ($MN)
North America Next Generation Cancer Diagnostics Market Outlook, By Leukemia (2013-2022) ($MN)
North America Next Generation Cancer Diagnostics Market Outlook, By Lymphoma (2013-2022) ($MN)
North America Next Generation Cancer Diagnostics Market Outlook, By Lung Cancer (2013-2022) ($MN)
North America Next Generation Cancer Diagnostics Market Outlook, By Solid tumors (2013-2022) ($MN)
North America Next Generation Cancer Diagnostics Market Outlook, By Colorectal Cancer (2013-2022) ($MN)
North America Next Generation Cancer Diagnostics Market Outlook, By Other Cancers (2013-2022) ($MN)
Europe Next Generation Cancer Diagnostics Market Outlook, By Application (2013-2022) ($MN)
Europe Next Generation Cancer Diagnostics Market Outlook, By Proteomic Analysis (2013-2022) ($MN)
Europe Next Generation Cancer Diagnostics Market Outlook, By Epigenetic Analysis (2013-2022) ($MN)
Europe Next Generation Cancer Diagnostics Market Outlook, By Genetic Analysis (2013-2022) ($MN)
Europe Next Generation Cancer Diagnostics Market Outlook, By Biomarker Development (2013-2022) ($MN)
Europe Next Generation Cancer Diagnostics Market Outlook, By CTC Analysis (2013-2022) ($MN)
Europe Next Generation Cancer Diagnostics Market Outlook, By Technology (2013-2022) ($MN)
Europe Next Generation Cancer Diagnostics Market Outlook, By Lab-on-a-chip (2013-2022) ($MN)
Europe Next Generation Cancer Diagnostics Market Outlook, By DNA Microarrays (2013-2022) ($MN)
Europe Next Generation Cancer Diagnostics Market Outlook, By Multiplexed assays (2013-2022) ($MN)
Europe Next Generation Cancer Diagnostics Market Outlook, By RT-PCR & Multiplexing (2013-2022) ($MN)
Europe Next Generation Cancer Diagnostics Market Outlook, By Protein Microarrays (2013-2022) ($MN)
Europe Next Generation Cancer Diagnostics Market Outlook, By Cellular capture and identification (2013-2022) ($MN)
Europe Next Generation Cancer Diagnostics Market Outlook, By Next Generation Sequencing (2013-2022) ($MN)
Europe Next Generation Cancer Diagnostics Market Outlook, By Benchtop Sequencers (2013-2022) ($MN)
Europe Next Generation Cancer Diagnostics Market Outlook, By Other Technologies (2013-2022) ($MN)
Europe Next Generation Cancer Diagnostics Market Outlook, By Function (2013-2022) ($MN)
Europe Next Generation Cancer Diagnostics Market Outlook, By Prognosis Diagnostics (2013-2022) ($MN)
Europe Next Generation Cancer Diagnostics Market Outlook, By Companion Diagnostics (2013-2022) ($MN)
Europe Next Generation Cancer Diagnostics Market Outlook, By Cancer Screening (2013-2022) ($MN)
Europe Next Generation Cancer Diagnostics Market Outlook, By Risk Analysis (2013-2022) ($MN)
Europe Next Generation Cancer Diagnostics Market Outlook, By Therapeutic Monitoring (2013-2022) ($MN)
Europe Next Generation Cancer Diagnostics Market Outlook, By Cancer Type (2013-2022) ($MN)
Europe Next Generation Cancer Diagnostics Market Outlook, By Sex-related tumors (2013-2022) ($MN)
Europe Next Generation Cancer Diagnostics Market Outlook, By Cervical Cancer (2013-2022) ($MN)
Europe Next Generation Cancer Diagnostics Market Outlook, By Breast Cancer (2013-2022) ($MN)
Europe Next Generation Cancer Diagnostics Market Outlook, By Ovarian Cancer (2013-2022) ($MN)
Europe Next Generation Cancer Diagnostics Market Outlook, By Prostate Cancer (2013-2022) ($MN)
Europe Next Generation Cancer Diagnostics Market Outlook, By Blood-born cancers (2013-2022) ($MN)
Europe Next Generation Cancer Diagnostics Market Outlook, By Myeloma (2013-2022) ($MN)
Europe Next Generation Cancer Diagnostics Market Outlook, By Leukemia (2013-2022) ($MN)
Europe Next Generation Cancer Diagnostics Market Outlook, By Lymphoma (2013-2022) ($MN)
Europe Next Generation Cancer Diagnostics Market Outlook, By Lung Cancer (2013-2022) ($MN)
Europe Next Generation Cancer Diagnostics Market Outlook, By Solid tumors (2013-2022) ($MN)
Europe Next Generation Cancer Diagnostics Market Outlook, By Colorectal Cancer (2013-2022) ($MN)
Europe Next Generation Cancer Diagnostics Market Outlook, By Other Cancers (2013-2022) ($MN)
Asia Pacific Next Generation Cancer Diagnostics Market Outlook, By Application (2013-2022) ($MN)
Asia Pacific Next Generation Cancer Diagnostics Market Outlook, By Proteomic Analysis (2013-2022) ($MN)
Asia Pacific Next Generation Cancer Diagnostics Market Outlook, By Epigenetic Analysis (2013-2022) ($MN)
Asia Pacific Next Generation Cancer Diagnostics Market Outlook, By Genetic Analysis (2013-2022) ($MN)
Asia Pacific Next Generation Cancer Diagnostics Market Outlook, By Biomarker Development (2013-2022) ($MN)
Asia Pacific Next Generation Cancer Diagnostics Market Outlook, By CTC Analysis (2013-2022) ($MN)
Asia Pacific Next Generation Cancer Diagnostics Market Outlook, By Technology (2013-2022) ($MN)
Asia Pacific Next Generation Cancer Diagnostics Market Outlook, By Lab-on-a-chip (2013-2022) ($MN)
Asia Pacific Next Generation Cancer Diagnostics Market Outlook, By DNA Microarrays (2013-2022) ($MN)
Asia Pacific Next Generation Cancer Diagnostics Market Outlook, By Multiplexed assays (2013-2022) ($MN)
Asia Pacific Next Generation Cancer Diagnostics Market Outlook, By RT-PCR & Multiplexing (2013-2022) ($MN)
Asia Pacific Next Generation Cancer Diagnostics Market Outlook, By Protein Microarrays (2013-2022) ($MN)
Asia Pacific Next Generation Cancer Diagnostics Market Outlook, By Cellular capture and identification (2013-2022) ($MN)
Asia Pacific Next Generation Cancer Diagnostics Market Outlook, By Next Generation Sequencing (2013-2022) ($MN)
Asia Pacific Next Generation Cancer Diagnostics Market Outlook, By Benchtop Sequencers (2013-2022) ($MN)
Asia Pacific Next Generation Cancer Diagnostics Market Outlook, By Other Technologies (2013-2022) ($MN)
Asia Pacific Next Generation Cancer Diagnostics Market Outlook, By Function (2013-2022) ($MN)
Asia Pacific Next Generation Cancer Diagnostics Market Outlook, By Prognosis Diagnostics (2013-2022) ($MN)
Asia Pacific Next Generation Cancer Diagnostics Market Outlook, By Companion Diagnostics (2013-2022) ($MN)
Asia Pacific Next Generation Cancer Diagnostics Market Outlook, By Cancer Screening (2013-2022) ($MN)
Asia Pacific Next Generation Cancer Diagnostics Market Outlook, By Risk Analysis (2013-2022) ($MN)
Asia Pacific Next Generation Cancer Diagnostics Market Outlook, By Therapeutic Monitoring (2013-2022) ($MN)
Asia Pacific Next Generation Cancer Diagnostics Market Outlook, By Cancer Type (2013-2022) ($MN)
Asia Pacific Next Generation Cancer Diagnostics Market Outlook, By Sex-related tumors (2013-2022) ($MN)
Asia Pacific Next Generation Cancer Diagnostics Market Outlook, By Cervical Cancer (2013-2022) ($MN)
Asia Pacific Next Generation Cancer Diagnostics Market Outlook, By Breast Cancer (2013-2022) ($MN)
Asia Pacific Next Generation Cancer Diagnostics Market Outlook, By Ovarian Cancer (2013-2022) ($MN)
Asia Pacific Next Generation Cancer Diagnostics Market Outlook, By Prostate Cancer (2013-2022) ($MN)
Asia Pacific Next Generation Cancer Diagnostics Market Outlook, By Blood-born cancers (2013-2022) ($MN)
Asia Pacific Next Generation Cancer Diagnostics Market Outlook, By Myeloma (2013-2022) ($MN)
Asia Pacific Next Generation Cancer Diagnostics Market Outlook, By Leukemia (2013-2022) ($MN)
Asia Pacific Next Generation Cancer Diagnostics Market Outlook, By Lymphoma (2013-2022) ($MN)
Asia Pacific Next Generation Cancer Diagnostics Market Outlook, By Lung Cancer (2013-2022) ($MN)
Asia Pacific Next Generation Cancer Diagnostics Market Outlook, By Solid tumors (2013-2022) ($MN)
Asia Pacific Next Generation Cancer Diagnostics Market Outlook, By Colorectal Cancer (2013-2022) ($MN)
Asia Pacific Next Generation Cancer Diagnostics Market Outlook, By Other Cancers (2013-2022) ($MN)
Rest of the World Next Generation Cancer Diagnostics Market Outlook, By Application (2013-2022) ($MN)
Rest of the World Next Generation Cancer Diagnostics Market Outlook, By Proteomic Analysis (2013-2022) ($MN)
Rest of the World Next Generation Cancer Diagnostics Market Outlook, By Epigenetic Analysis (2013-2022) ($MN)
Rest of the World Next Generation Cancer Diagnostics Market Outlook, By Genetic Analysis (2013-2022) ($MN)
Rest of the World Next Generation Cancer Diagnostics Market Outlook, By Biomarker Development (2013-2022) ($MN)
Rest of the World Next Generation Cancer Diagnostics Market Outlook, By CTC Analysis (2013-2022) ($MN)
Rest of the World Next Generation Cancer Diagnostics Market Outlook, By Technology (2013-2022) ($MN)
Rest of the World Next Generation Cancer Diagnostics Market Outlook, By Lab-on-a-chip (2013-2022) ($MN)
Rest of the World Next Generation Cancer Diagnostics Market Outlook, By DNA Microarrays (2013-2022) ($MN)
Rest of the World Next Generation Cancer Diagnostics Market Outlook, By Multiplexed assays (2013-2022) ($MN)
Rest of the World Next Generation Cancer Diagnostics Market Outlook, By RT-PCR & Multiplexing (2013-2022) ($MN)
Rest of the World Next Generation Cancer Diagnostics Market Outlook, By Protein Microarrays (2013-2022) ($MN)
Rest of the World Next Generation Cancer Diagnostics Market Outlook, By Cellular capture and identification (2013-2022) ($MN)
Rest of the World Next Generation Cancer Diagnostics Market Outlook, By Next Generation Sequencing (2013-2022) ($MN)
Rest of the World Next Generation Cancer Diagnostics Market Outlook, By Benchtop Sequencers (2013-2022) ($MN)
Rest of the World Next Generation Cancer Diagnostics Market Outlook, By Other Technologies (2013-2022) ($MN)
Rest of the World Next Generation Cancer Diagnostics Market Outlook, By Function (2013-2022) ($MN)
Rest of the World Next Generation Cancer Diagnostics Market Outlook, By Prognosis Diagnostics (2013-2022) ($MN)
Rest of the World Next Generation Cancer Diagnostics Market Outlook, By Companion Diagnostics (2013-2022) ($MN)
Rest of the World Next Generation Cancer Diagnostics Market Outlook, By Cancer Screening (2013-2022) ($MN)
Rest of the World Next Generation Cancer Diagnostics Market Outlook, By Risk Analysis (2013-2022) ($MN)
Rest of the World Next Generation Cancer Diagnostics Market Outlook, By Therapeutic Monitoring (2013-2022) ($MN)
Rest of the World Next Generation Cancer Diagnostics Market Outlook, By Cancer Type (2013-2022) ($MN)
Rest of the World Next Generation Cancer Diagnostics Market Outlook, By Sex-related tumors (2013-2022) ($MN)
Rest of the World Next Generation Cancer Diagnostics Market Outlook, By Cervical Cancer (2013-2022) ($MN)
Rest of the World Next Generation Cancer Diagnostics Market Outlook, By Breast Cancer (2013-2022) ($MN)
Rest of the World Next Generation Cancer Diagnostics Market Outlook, By Ovarian Cancer (2013-2022) ($MN)
Rest of the World Next Generation Cancer Diagnostics Market Outlook, By Prostate Cancer (2013-2022) ($MN)
Rest of the World Next Generation Cancer Diagnostics Market Outlook, By Blood-born cancers (2013-2022) ($MN)
Rest of the World Next Generation Cancer Diagnostics Market Outlook, By Myeloma (2013-2022) ($MN)
Rest of the World Next Generation Cancer Diagnostics Market Outlook, By Leukemia (2013-2022) ($MN)
Rest of the World Next Generation Cancer Diagnostics Market Outlook, By Lymphoma (2013-2022) ($MN)
Rest of the World Next Generation Cancer Diagnostics Market Outlook, By Lung Cancer (2013-2022) ($MN)
Rest of the World Next Generation Cancer Diagnostics Market Outlook, By Solid tumors (2013-2022) ($MN)
Rest of the World Next Generation Cancer Diagnostics Market Outlook, By Colorectal Cancer (2013-2022) ($MN)
Rest of the World Next Generation Cancer Diagnostics Market Outlook, By Other Cancers (2013-2022) ($MN)
